LONDON, 22 June 2026 - KAI Conversations and Baringa today announced a strategic collaboration to help pharmaceutical organisations accelerate growth, improve execution and realise greater value from commercial, medical, learning and development, and AI investments.
Pharmaceutical companies invest billions every year in launches, field teams, learning programmes, content and AI. Yet many still struggle to understand which investments are creating measurable value. Too often, they rely on lagging metrics that arrive months after critical decisions have already been made.
The missing link is understanding what is changing with customers before commercial results appear creating leading indicators of adoption, influence and future performance.
KAI was built to measure the missing KPI: behaviour change.
Because behaviour change sits behind every successful launch, capability programme, AI investment and commercial transformation.
Used by 12 of the world’s top 20 pharmaceutical companies across 35+ markets, 15+ therapy areas and more than 40,000 real-world healthcare conversations, KAI helps organisations understand whether investments are translating into adoption, launch performance, field effectiveness and growth.
“Most platforms tell pharma what happened, the activity. KAI helps explain why performance is improving or declining and how to drive future growth. That’s the difference between reporting activity and driving outcomes,” said David Williams, Founder and CEO of KAI Conversations.
Knowing what works is not enough. The real challenge is scaling it consistently across markets, brands and teams. Insight alone does not change behaviour. Turning insight into growth requires more than visibility. It requires execution at scale.
That is where Baringa comes in.
Baringa helps clients translate KAI’s insights into capability programmes, operating models and transformation initiatives that drive consistent execution at scale.
“The organisations that can see early what is driving adoption, confidence and decision-making gain an advantage long before it appears in revenue. Growth leaves signals before it leaves results,” said Paula Dias Figueiredo, Non-Executive Director at KAI Conversations.
“Rich interactions between healthcare professionals and field teams contain signals that rarely make it into traditional systems,” said David Logue, Partner, Pharma & Life Sciences at Baringa. “With KAI, we’re helping pharma companies hear real-time insights so they can optimise what matters, connect humans in healthcare to help patients who can’t wait.”
“What’s becoming clear in our work with clients is that the challenge is no longer access to insight. It’s turning that insight into consistent behaviour in the field,” said Laura Dix, Partner, Pharma & Life Sciences at Baringa. “KAI brings a step-change in visibility into the quality of real conversations, and our role is to help organisations translate that into coaching, capability and ways of working that genuinely stick. It’s that combination that ultimately turns insight into impact.”
Together, KAI and Baringa help life sciences organisations:
• Accelerate launch adoption
• Improve commercial performance
• Increase productivity from field and medical teams
• Scale best practices faster across markets
• Increase ROI from AI, capability and transformation investments
• Create faster organisational learning loops
About KAI Conversations
KAI Conversations is a Growth Intelligence platform purpose-built for life sciences. By transforming commercial and medical interactions into behavioural signals, KAI helps organisations understand whether launches, capability programmes, learning initiatives, content and AI investments are changing behaviour before commercial results appear.
Used by 12 of the world’s top 20 pharmaceutical companies across 35+ markets, 15+ therapy areas and more than 40,000 real-world healthcare conversations, KAI helps leaders connect activity to outcomes, accelerate learning and improve commercial performance.
About Baringa
Baringa is a global management consultancy helping organisations accelerate transformation and deliver measurable business outcomes. Baringa works with many of the world’s leading life sciences organisations to translate strategy into execution, capability into performance, and transformation into sustainable organisational change.
Contact:
David Williams
Founder & CEO, KAI Conversations
Email: hello@kaiconversations.com